http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
배일헌,한기석,차상훈,김성진,박길선,한설희,김동호 충북대학교 의학연구소 2002 忠北醫大學術誌 Vol.12 No.2
연구목적: 본 연구의 목적은 초음파 유도 하에 갑상선 결절을 경피적 흡인 생검 할 때 검체 획득률을 알아 보고, 검체 획득률에 영향을 주는 요소들을 알아보고자 하였다. 대상 및 방법: 갑상선 결절이 있어 초음파 유도하 경피적 흡인 생검을 하였던 132명 (12-71; 평균 42세) 환자의 결절 215예를 대상으로 전향적 연구를 시행하였다. 2000년 9월부터 2001년 2월까지 62명의 환자의 결절 111예에서 21-gauge 세침을 이용하였고, 2001년 3월부터 9월까지 70명의 환자의 결절 104예에서 20-gauge 절단침을 이용하였다. 초음파 유도하 경피적 흡인 생검의 검체 획득률을 구하였고, 결절 단경이 1 ㎝ 이하와 1 ㎝ 초과, 결절의 성상, 촉지여부에 따라 검체 확득률에 차이가 있는지 비교 분석하였다. 통계적 분석은 Chisquare test로 검증하였다 (p<0.05). 결과: 총 215예 중 188예에서 적절한 검체가 얻어져 전체 검체 획득률은 87.4%이었다. 낭성 결절 (78.8%)보다 고형 결절 (90.2%)에서 더 높은 검체 획득율을 보였으나, 결절의 크기(≤1 ㎝:85.7% vs. >1 ㎝:88.7%)와 촉지 여부 (촉지되는 결절: 87.5% vs. 촉지되지 않는 결절:87.4%)에 따라서는 유의한 차이를 보이지 않았다. 결론: 갑상선 결절의 초음파 유도하 경피적 흡인 생검은 높은 검체 획득율을 보이며, 결절의 크기, 촉지 여부에 따른 차이는 없으나, 고형 결절에서 낭성 결절보다 높은 검체 획득율을 보인다. Purpose: The purpose of this study is to evaluate the acquisition rate of adequate specimen in ultrasound-guided percutaneous needle aspiration biopsy (US-PCNB) of thyroid nodules and to find the factors influencing the acquisition rate. Materials and Methods: We conducted a prospective study in 132 patients (mean age 47 years: range 12-71) who had 215 nodules. Aspiration biopsy was performed with 21-gauge fine needles for 111 nodules (62 patients) and with 20-gauge cutting needles for 104 nodules (70 patients). We calculated overall acquisition rate of adequate specimen of US-PCNB and compared acquisition rates according to nodule size, nature and palpability. Results: Total acquisition rate of adequate specimen was 87.4%. The acquisition rate of adequate specimen of solid nodules (90.2%) was higher than that of cystic nodules (78.8%). The size of nodules did not affect the acquisition rate of specimen (≤1 ㎝:85.7% vs. >1 ㎝:88.7%). The palpability of nodules also cause no difference the acquisition rate (palpable: 87.5% vs. non-palpable:87.4%). Conclusion: US-guided PCNB of thyroid nodules was high acquisition rate of adequate specimen. There was no statistically significant difference according to size and palpability of nodules but was according to nature of nodules in the acquisition rate of adequate specimen.
Park, Seol-Hoon,Ryu, Jin-Sook,Oh, Seung-Jun,Park, Seung-Il,Kim, Yong-Hee,Jung, Hoon-Yong,Lee, Gin-Hyug,Song, Ho-Jun,Kim, Jong-Hoon,Song, Ho-Young,Cho, Kyoung-Ja,Kim, Sung-Bae The Korea Society of Nuclear Medicine 2012 핵의학 분자영상 Vol.46 No.1
Purpose : The aim of this study was to determine whether $^{18}F$-fluorothymidine (FLT) PET is feasible for the early prediction of tumor response to induction chemotherapy followed by concurrent chemoradiotherapy in patients with esophageal cancer. Methods : This study was prospectively performed as a collateral study of "randomized phase II study of preoperative concurrent chemoradiotherapy with or without induction chemotherapy with S-1/oxaliplatin in patients with resectable esophageal cancer". $^{18}F$-FLT positron emission tomography (PET) images were obtained before and after two cycles of induction chemotherapy, and the percent change of maximum standardized uptake value (SUVmax) was calculated. All patients underwent esophagography, gastrofiberoscopy, endoscopic ultrasonography (EUS), computed tomography (CT) and $^{18}F$-fluorodeoxyglucose (FDG) PET at baseline and 3-4 weeks after completion of concurrent chemoradiotherapy. Final tumor response was determined by both clinical and pathologic tumor responses after surgery. Results : The 13 patients for induction chemotherapy group were enrolled until interim analysis. In a primary tumor visual analysis, the tumor detection rates of baseline $^{18}F$-FLT and $^{18}F$-FDG PET were 85% and 100%, respectively. The tumor uptakes on $^{18}F$-FLT PET were lower than those of $^{18}F$-FDG PET. Among nine patients who completed second $^{18}F$-FLT PET, eight patients were responders and one patient was a non-responder in the assessment of final tumor response. The percent change of SUVmax in responders ranged from 41.2% to 79.2% (median 57.1%), whereas it was 10.2% in one non-responder. Conclusion : The percent change of tumor uptake in $^{18}F$-FLT PET after induction chemotherapy might be feasible for early prediction of tumor response after induction chemotherapy and concurrent chemoradiotherapy in patients with esophageal cancer.
Park, Chul-Kee,Kim, Jeong Hoon,Nam, Do-Hyun,Kim, Chae-Yong,Chung, Sang-Bong,Kim, Young-Hoon,Seol, Ho Jun,Kim, Tae Min,Choi, Seung Hong,Lee, Se-Hoon,Heo, Dae Seog,Kim, Il Han,Kim, Dong Gyu,Jung, Hee-Wo Oxford University Press 2013 Neuro-oncology Vol.15 No.8
<P><B>Background</B></P><P>To determine the benefit of surgical management in recurrent glioblastoma, we analyzed a series of patients with recurrent glioblastoma who had undergone surgery, and we devised a new scale to predict their survival.</P><P><B>Methods</B></P><P>Clinical data from 55 consecutive patients with recurrent glioblastoma were evaluated after surgical management. Kaplan–Meier survival analysis and Cox proportional hazards regression modeling were used to identify prognostic variables for the development of a predictive scale. After the multivariate analysis, performance status (<I>P</I> = .078) and ependymal involvement (<I>P</I> = .025) were selected for inclusion in the new prognostic scale. The devised scale was validated with a separate set of 96 patients from 3 different institutes.</P><P><B>Results</B></P><P>A 3-tier scale (scoring range, 0–2 points) composed of additive scores for the Karnofsky performance status (KPS) (0 for KPS ≥ 70 and 1 for KPS < 70) and ependymal involvement (0 for no enhancement and 1 for enhancement of the ventricle wall in the magnetic resonance imaging) significantly distinguished groups with good (0 points; median survival, 18.0 months), intermediate (1 point; median survival, 10.0 months), and poor prognoses (2 points; median survival, 4.0 months). The new scale was successfully applied to the validation cohort of patients showing distinct prognosis among the groups (median survivals of 11.0, 9.0, and 4.0 months for the 0-, 1-, and 2-point groups, respectively).</P><P><B>Conclusions</B></P><P>We developed a practical scale to facilitate deciding whether to proceed with surgical management in patients with recurrent glioblastoma. This scale was useful for the diagnosis of prognostic groups and can be used to develop guidelines for patient treatment.</P>
Osteopromotion With Synthetic Oligopeptide-Coated Bovine Bone Mineral In Vivo
Park, Jun-Beom,Lee, Jue-Yeon,Park, Ho-Nam,Seol, Yang-Jo,Park, Yoon-Jeong,Rhee, Sang-Hoon,Lee, Sang-Cheol,Kim, Kyoung-Hwa,Kim, Tae-Il,Lee, Yong-Moo,Ku, Young,Rhyu, In-Chul,Han, Soo-Boo,Chung, Chong-Pyo Wiley (John WileySons) 2007 Journal of periodontology Vol.78 No.1
Reoperation of prosthetic tricuspid valve failure with acquired cyanosis
( Bomin Park ),( Sang Hoon Seol ),( Seung Hyun Park ),( Joo Won Lee ),( Dong Ki Kim ),( Ki Hoon Kim ),( Doo Il Kim ) 대한내과학회 2011 대한내과학회 추계학술발표논문집 Vol.2011 No.1
A 78 years old woman visited emergency room with dyspnea started 12 years ago and aggravated 2 weeks ago. She had a cardiac operation 17 years ago, that was repair of atrial septal defect secundum type and bioprosthetic replacement of tricuspid valve. Her fingers were cyanotic and clubbing. Electrocardiogram showed atrial fibrillation and incomplete right bundle branch block. Chest X-ray showed marked cardiomegaly and chest CT showed large mass in right atrium and atrial septal defect. Echocardiography revealed thickening of bioprosthetic tricuspid valve with severe tricuspid stenosis and moderate tricuspid regurgitation(fig.1-A). And atrial septal defect with right to left shunt, large thrombus at right atrium were detected(fig.1-B). Her bioprosthetic tricuspid valve was replaced, atrial septal defect was closed by patch and thrombus was removed. After operation cyanosis was disappeared and chest X-ray showed improved cardiomegaly. We report this case successful reoperation in patient with cyanosis because of atrial septal defect with right to left shunt and severe tricuspid stenosis and regurgitation.
A fatal acute right heart failure with elevated D-dimer in gastric cancer pateint
( Seung Hyun Park ),( Sang Hoon Seol ),( Joo Won Lee ),( Ho Chan Sim ),( Bo Min Park ),( Dong Ki Kim ),( Ki Hoon Kim ),( Doo Il Kim ) 대한내과학회 2011 대한내과학회 추계학술발표논문집 Vol.2011 No.1
A 46-year-old woman with gastric cancer presented with a 2 week period of progressively worsening shortness of breath. Six months ealier, she had a total gastrectomy. However, the adjuvant chemotherapy was not done because of her refusal. On admission, the physical examination including auscultation was unremarkable. The patient was afebrile patient, with tachycardia of 116/min, a respiratory rate of 28/min and a blood pressure of 100 /60 mmHg. Laboratory findings were remarkable for microcytic anemia and a strong positive D dimer (11.8 ug/mL, normal <0.55). Electrocardiography showed sinus tachycardia. Echocardiography revealed feature of pulmonary hypertension, namely a severely dilated right ventricle with grossly impaired systolic function and an estimated pulmonary artery pressure of 70 mmHg (Fig. 1). Chest CT presented no evidence of pulmonary emboli (Fig. 2). She rapidly developed hypoxemic respiratory failure and desaturated 80% on 10 liters of oxygen. The patient`s condition progressively worsened and took a rapid downhill course, despite aggressive hemodynamic support. Finally, the patient developed an intractable respiratory failure and died 14 hours after hospitalization.
An interesting case of pulmonary embolism
( Seung Hyun Park ),( Sang Hoon Seol ),( Joo Won Lee ),( Ho Chan Sim ),( Bo Min Park ),( Dong Ki Kim ),( Ki Hoon Kim ),( Doo Il Kim ) 대한내과학회 2011 대한내과학회 추계학술발표논문집 Vol.2011 No.1
A 41-year-old man presented to the emergency department complaining of dyspnea and left-sided pleuritic chest pain. He had been admitted and treated for pulmonary thromboembolism 10 years ago. However, he stopped the medication in 6 months. His both legs were swelling with pitting edema. Laboratory results showed an elevated D-dimer serum level (6.3 ug/mL, normal <0.55). Anticardiolipin antibodies and lupus anticoagulant were not detected. Protein C and protein S levels were normal. Electrocardiogram showed sinus tachycardia, right ventricular hypertrophy. Chest computed tomography revealed thrombus in the enlarged main pulmonary trunk, left lobar branch and total occlusion of right middle and lower lobar branch (Fig.1).Echocardiography showed a right ventricular overloading sign with severe pulmonary hypertension (pressure gradient 158 mmHg), severe tricuspid regurgitation, and D-shaped left ventricle(Fig. 2). The patient received standard anticoagulant. Computed tomography of venogram showed diffuse thrombus at inferior vena cava (IVC), from suprarenal IVC to iliac vein to femoral vein to popliteal vein to calf veins. After a 20-day course of hospital treatment, IVC venogram showed no visible thrombotic filling defect at IVC and right femoral vein. but left femoral venous flow was sluggish. Lower legs Doppler ultrasound didn`t revealed visible thrombus. He still had pulmonary hypertension (85mmHg) at the end of 2 months follow-up. However, the patient`s symptom improved and continued taking oral anticoagulation therapy.